These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Homocellular conduction along endothelium and smooth muscle of arterioles in hamster cheek pouch: unmasking an NO wave. Budel S; Bartlett IS; Segal SS Circ Res; 2003 Jul; 93(1):61-8. PubMed ID: 12791708 [TBL] [Abstract][Full Text] [Related]
68. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart. Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194 [TBL] [Abstract][Full Text] [Related]
69. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries. Grant S; Lutz EM; McPhaden AR; Wadsworth RM J Cereb Blood Flow Metab; 2006 Jan; 26(1):58-67. PubMed ID: 15959462 [TBL] [Abstract][Full Text] [Related]
70. Vasoactive intestinal polypeptide and acetylcholine are responsible for neurovasodilation in the head of the cat. Bevan JA; Brayden JE; Buga GM; Moskowitz MA; Said SI J Hypertens Suppl; 1984 Dec; 2(3):S427-9. PubMed ID: 6599693 [TBL] [Abstract][Full Text] [Related]
71. Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin. Wilkins BW; Chung LH; Tublitz NJ; Wong BJ; Minson CT J Appl Physiol (1985); 2004 Oct; 97(4):1291-8. PubMed ID: 15155712 [TBL] [Abstract][Full Text] [Related]
73. Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows. Nilsson SF; Bill A Acta Physiol Scand; 1984 Aug; 121(4):385-92. PubMed ID: 6148840 [TBL] [Abstract][Full Text] [Related]
74. Human VIP-alpha: a long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension. Onyüksel H; Séjourné F; Suzuki H; Rubinstein I Peptides; 2006 Sep; 27(9):2271-5. PubMed ID: 16621151 [TBL] [Abstract][Full Text] [Related]
75. Muscarinic modulation of the vasodilatory effects of vasoactive intestinal peptide at the rat thyroid gland. Huffman LJ; Michalkiewicz M; Connors JM; Pietrzyk Z; Hedge GA Neuroendocrinology; 1991 Jan; 53(1):69-74. PubMed ID: 2046862 [TBL] [Abstract][Full Text] [Related]
76. Short-term exposure to lipopolysaccharide is associated with microvascular contractile dysfunction in vivo. Gao XP; Suzuki H; Olopade CO; Rubinstein I Life Sci; 1995 Mar; 56(15):1243-9. PubMed ID: 8614241 [TBL] [Abstract][Full Text] [Related]
77. Neurogenic vasodilation in rabbit basilar isolated artery: involvement of calcitonin-gene related peptide. Olivar T; Razzaque Z; Nwagwu M; Longmore J Eur J Pharmacol; 2000 Apr; 395(1):61-8. PubMed ID: 10781675 [TBL] [Abstract][Full Text] [Related]
78. Interaction of amylin with calcitonin gene-related peptide receptors in the microvasculature of the hamster cheek pouch in vivo. Hall JM; Brain SD Br J Pharmacol; 1999 Jan; 126(1):280-4. PubMed ID: 10051146 [TBL] [Abstract][Full Text] [Related]
79. Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro. Liu YC; Khawaja AM; Rogers DF Br J Pharmacol; 1999 Nov; 128(6):1353-9. PubMed ID: 10578152 [TBL] [Abstract][Full Text] [Related]
80. Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle. Vicaut E; Hou X; Payen D; Bousseau A; Tedgui A J Clin Invest; 1991 May; 87(5):1537-40. PubMed ID: 2022725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]